Medical News

RSS

Baby swimming develops balance and movement in infants and young children

Teaching babies to swim turns out to be more than just fun. Baby swimmers have better balance and are also better at grasping at things than non-swimmers.

29 Apr 2010

US Senate concentrates on benefits of new wireless medical technology: EHSI

Emerging Healthcare Solutions, Inc. applauded news that the US Senate Committee on Aging was beginning to concentrate on the benefits of new wireless medical technology, a sector that includes the Company's MedAnywhere iPhone application which is currently in development. The Committee began the review last week.

29 Apr 2010

Isis Maternity is now Isis Parenting

Today, Isis Maternity, The Place for Expecting and New Moms, becomes Isis, Parenting Starts Here. This change reflects the breadth of education, products and community that Isis delivers to its clients. Since opening its doors in 2003, Isis has helped more than 35,000 families navigate early parenting from pregnancy to preschool.

29 Apr 2010

Blind and sighted individuals have similar smell perception

An ongoing study by Mathilde Beaulieu-Lefebvre, a graduate student from the Universit- de Montr-al Department of Psychology, has debunked the myth that the blind have a more acute sense of smell than the sighted.

29 Apr 2010

Dental clinic reveals need in Los Angeles area while North Carolina County may cut dental care for many Medicaid patients

More than 100 who had waited for care were asked to return next week for services. In all, volunteers saw 1,157 patients, 64 of them minors. Overwhelmed by demand for dental services, organizers of a massive free mobile health clinic asked some patients who had Tuesday appointments to return next week, a hitch in an otherwise smooth first day at the Los Angeles Memorial Sports Arena.

29 Apr 2010

Talecris Biotherapeutics first-quarter net income increases 35.6% to $45.3 million

Talecris Biotherapeutics Holdings Corp. today announced its financial results for the three months ended March 31, 2010, and filed its first quarter 2010 Form 10-Q with the U.S. Securities and Exchange Commission (SEC).

29 Apr 2010

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.

29 Apr 2010

Study calls for optimized medical treatment for older patients with advanced lung cancer

Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce.

29 Apr 2010

Overhaul may cost drugmakers more than expected

Bloomberg BusinessWeek: The health overhaul legislation will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts. "The extra costs will come from expanding drug rebates through Medicaid, the U.S. insurance program for the poor, [Leerink Swann & Co executive] John L. Sullivan said today at a Bloomberg conference in Chicago."

29 Apr 2010

Salix Pharmaceuticals receives FDA complete response letter for GIAZO Tablets NDA

Salix Pharmaceuticals, Ltd. today announced the Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for GIAZO™ (balsalazide disodium) Tablets 1.1 g. for the treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.

29 Apr 2010

Combination of antibiotics can cure Chlamydia-induced ReA: Study

Researchers from University of South Florida College of Medicine found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, a major step forward in the management, and possibly cure, of this disease. Results of this study are published in the May issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

29 Apr 2010

A new approach for treating neurological and degenerative disorders

In studies on cancer, heart disease, neurological disorders and other degenerative conditions, some scientists are moving away from the "nature versus nurture" debate, and are finding you're not a creature of either genetics or environment, but both - with enormous implications for a new approach to health.

29 Apr 2010

Odyssey HealthCare reports 53.7% increase in first-quarter net income attributable to stockholders

Odyssey HealthCare, Inc., one of the largest providers of hospice care in the United States, today announced financial results for the first quarter ended March 31, 2010.

29 Apr 2010

Great American Asthma Challenge movement to change asthma care in the U.S.

Every day 10 people die from asthma. Most healthcare providers agree that these deaths are preventable. Patient education, access to care and a healthy lifestyle are proven methods that lead to less severe asthma symptoms, fewer hospitalizations and emergency department visits, fewer missed days of school and work - and fewer deaths.

29 Apr 2010

Three new biomarkers for ductal carcinoma in situ found

A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.

29 Apr 2010

Healthy food programs in grocery stores may help reduce diet-related illnesses

Bringing healthy food programs to corner grocery stores in the inner city might be a step toward improving residents' diet and reducing diet-related illnesses, a new study suggests.

29 Apr 2010

Celladon's first Phase II trial of MYDICAR for advanced heart failure meets primary endpoint

Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.

29 Apr 2010

ONDCP launches new anti-meth ad campaign for Indian Country

White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.

29 Apr 2010

China lifts decades-old HIV/AIDS travel ban

Late Tuesday, China's State Council lifted a decades-old restriction that banned foreigners with HIV/AIDS from entering the country, Reuters reports (Buckley, 4/27). The amended rules, which appear on the government website, also lift a travel ban on foreigners with other sexually transmitted diseases and leprosy, and "narrow the travel restriction on people with tuberculosis, to those with an infectious form of the lung disease," according to Bloomberg Businessweek (Randall, 4/28).

29 Apr 2010

Young adults seeking coverage on parents' plans face obstacles

Young adults and their parents eager to take advantage of a new law that will allow parents of children up to age 26 to keep their children on their health plans are facing obstacles in learning even exactly when they'll be eligible.

29 Apr 2010